ALK Abell (Denmark) Top Management
ALK-B Stock | DKK 158.50 3.80 2.46% |
ALK Abell employs about 2.7 K people. The company is managed by 10 executives with a total tenure of roughly 6254 years, averaging almost 625.0 years of service per executive, having 268.0 employees per reported executive. Evaluation of ALK Abell's management performance can provide insight into the firm performance.
Soren Jelert Insider Ex CFO |
Carsten Hellmann Insider CEO Pres |
ALK |
ALK Abell Management Team Effectiveness
The company has return on total asset (ROA) of 0.0516 % which means that it generated a profit of $0.0516 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0897 %, meaning that it generated $0.0897 on every $100 dollars invested by stockholders. ALK Abell's management efficiency ratios could be used to measure how well ALK Abell manages its routine affairs as well as how well it operates its assets and liabilities.ALK Abell Workforce Comparison
ALK Abell AS is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 32,480. ALK Abell holds roughly 2,680 in number of employees claiming about 8% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.11 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.11. ALK Abell AS Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. ALK Abell AS Price Series Summation is a cross summation of ALK Abell price series and its benchmark/peer.
ALK Abell Notable Stakeholders
An ALK Abell stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ALK Abell often face trade-offs trying to please all of them. ALK Abell's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ALK Abell's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Soren Jelert | Ex CFO | Profile | |
Carsten Hellmann | CEO Pres | Profile | |
Miles Guralnick | Pres Inc | Profile | |
Sren Jelert | Ex CFO | Profile | |
Per Plotnikof | Investor Communications | Profile | |
Christian Houghton | Head Supply | Profile | |
Henrik Jacobi | Ex Management | Profile | |
Katja Thalund | Project Director | Profile | |
Pr MD | Sr Markets | Profile | |
Sren Niegel | Ex Board | Profile |
About ALK Abell Management Performance
The success or failure of an entity such as ALK Abell AS often depends on how effective the management is. ALK Abell management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ALK management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ALK management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ALK-Abell AS, a pharmaceutical company, develops and markets products and services for allergy and allergic asthma in Europe, North America, and internationally. ALK-Abell AS was founded in 1923 and is headquartered in Hrsholm, Denmark. ALK Abell operates under Biotechnology classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 2379 people.
Please note, the presentation of ALK Abell's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ALK Abell's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ALK Abell's management manipulating its earnings.
ALK Abell Workforce Analysis
Traditionally, organizations such as ALK Abell use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ALK Abell within its industry.ALK Abell Manpower Efficiency
Return on ALK Abell Manpower
Revenue Per Employee | 1.7M | |
Revenue Per Executive | 451.1M | |
Net Income Per Employee | 125K | |
Net Income Per Executive | 33.5M | |
Working Capital Per Employee | 297K | |
Working Capital Per Executive | 79.6M |
Complementary Tools for ALK Stock analysis
When running ALK Abell's price analysis, check to measure ALK Abell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ALK Abell is operating at the current time. Most of ALK Abell's value examination focuses on studying past and present price action to predict the probability of ALK Abell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ALK Abell's price. Additionally, you may evaluate how the addition of ALK Abell to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |